Braille Aluminum Jumbo slate, 4 x 18, pins down
by LS&S
Last verified June 18, 2026 · classified April 26, 2026
What it is
Summary
AI-generated from vendor-published content · April 26, 2026
A braille writing slate made from aluminum with an 18-cell by 4-line grid, used with a pointed stylus to manually emboss braille dots into paper. It's designed for people who are blind or have significant vision loss and want a portable, low-tech way to write braille by hand — no power required. This is a complete, ready-to-use tool that comes with a plastic stylus; you'll need your own braille paper to write on. The 'pins down' orientation means dots are pushed away from you as you write, which is the standard method — worth confirming this matches your learned technique before purchasing, since some braille writers prefer pins-up slates.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- School district
- Vocational rehab
What Setup Looks Like
- Out of the box
- Insert a sheet of braille paper into the slate between the two frames.
- Use the included stylus to press dots into each cell, working right to left across each row.
- Remove the paper and flip it over to read the embossed braille.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
How to Fund This
Equipment like this is often pursued through official state programs. These are common starting points — each program decides its own eligibility and what it covers, so the first step is always a phone call.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from LS&S — view on vendor site; last verified June 18, 2026.
Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.